Patrick R. Trucchio Analyst PerformanceManaging Director of Equity Research at HC WainwrightPatrick R. Trucchio is a stock analyst at HC Wainwright focused in the healthcare sector, covering 38 publicly traded companies. Over the past year, Patrick R. Trucchio has issued 129 stock ratings, including buy and hold recommendations. While full access to Patrick R. Trucchio's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Patrick R. Trucchio's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings330 Last 6 YearsBuy Recommendations99.39% 325 Buy RatingsCompanies Covered38 Unique Companies Ratings Distribution327RatingsDistribution of strong buy, buy, hold, and sell ratings by Patrick R. Trucchio.RatingPercentageCount Strong Buy0.0%0 ratings Buy99.4%325 ratings Hold0.6%2 ratings Sell0.0%0 ratingsOut of 327 total stock ratings issued by Patrick R. Trucchio at HC Wainwright, the majority (99.4%) have been Buy recommendations, followed by 0.6% Hold.Best & Worst CallsBest Call000000.0%ANROApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BNTCFeb 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ81.6% of companies on NASDAQ31 companiesTSE7.9% of companies on TSE3 companiesOTCMKTS5.3% of companies on OTCMKTS2 companiesNYSE2.6% of companies on NYSE1 companyCVE2.6% of companies on CVE1 companyPatrick R. Trucchio, an analyst at HC Wainwright, currently covers 38 companies listed on NASDAQ, TSE, OTCMKTS, NYSE and CVE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare37 companies97.4%Finance1 company2.6%Patrick R. Trucchio of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on Finance companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY24 companies63.2%PHARMACEUTICALS12 companies31.6%BANKS1 company2.6%HEALTHCARE PROVIDERS & SERVICES1 company2.6% About Patrick R. TrucchioMr. Trucchio is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on biotechnology, specifically on inflammation, fibrosis, cardio-metabolic, CNS, and rare diseases in addition to other areas. Mr. Trucchio has thirteen years of research experience on the sell-side. Prior to joining H.C. Wainwright, Mr. Trucchio was a senior equity research analyst at Berenberg Capital Markets (BCM) covering biotechnology and specialty pharmaceutical companies. Prior to Berenberg Capital Markets, Mr. Trucchio worked at Wells Fargo Securities and BMO Capital Markets. At Wells Fargo, Mr Trucchio worked on an Institutional Investor ranked analyst team covering specialty pharmaceutical companies. Mr. Trucchio’s educational background includes an M.B.A. with Honors from St. John’s University and a B.S. in Finance from The Pennsylvania State University.Follow on LinkedIn Patrick R. Trucchio's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsALNYAlnylam Pharmaceuticals9/21/2026Reiterated Rating$239.56$455.00Buy$0.0000.00% ROIAGMBAgomAb Therapeutics9/16/2026Reiterated Rating$12.16Buy$0.0000.00% ROIDFTXDefinium Therapeutics9/14/2026Reiterated Rating$40.60$70.00Buy$0.0000.00% ROIPHVSPharvaris9/8/2026Reiterated Rating$38.35$60.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals9/2/2026Reiterated Rating$246.11$455.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals9/1/2026Reiterated Rating$82.39$120.00Buy$0.0000.00% ROIGOSSGossamer Bio8/27/2026Reiterated Rating$0.17Buy$0.0000.00% ROIVYGRVoyager Therapeutics8/27/2026Reiterated Rating$3.46Buy$0.0000.00% ROIBEAMBeam Therapeutics8/25/2026Reiterated Rating$28.33$80.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals8/25/2026Reiterated Rating$3.55Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ONCYOncolytics Biotech8/19/2026Lower Price Target$0.84$5.00Buy$0.0000.00% ROIDRUGBright Minds Biosciences8/19/2026Reiterated Rating$84.86$145.00Buy$0.0000.00% ROIIVVDInvivyd8/18/2026Reiterated Rating$0.74Buy$0.0000.00% ROIASMBAssembly Biosciences8/18/2026Reiterated Rating$30.01$50.00Buy$0.0000.00% ROIANROAlto Neuroscience8/17/2026Boost Price Target$33.56$55.00Buy$0.0000.00% ROIFTHSensei Biotherapeutics8/11/2026Reiterated Rating$28.57$60.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals8/10/2026Reiterated Rating$3.58Buy$0.0000.00% ROIGHRSGH Research8/10/2026Reiterated Rating$30.27Buy$0.0000.00% ROIBEAMBeam Therapeutics8/10/2026Reiterated Rating$27.48Buy$0.0000.00% ROIVYGRVoyager Therapeutics8/10/2026Reiterated Rating$3.27Buy$0.0000.00% ROICMPSCompass Pathways8/7/2026Lower Price Target$13.55$65.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals8/6/2026Boost Price Target$85.51$120.00Buy$0.0000.00% ROIDTILPrecision BioSciences8/3/2026Reiterated Rating$6.99Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals7/31/2026Lower Price Target$205.48$455.00Buy$0.0000.00% ROIALTAltimmune7/28/2026Reiterated Rating$2.88Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals7/27/2026Boost Price Target$85.60$115.00Buy$0.0000.00% ROIGOSSGossamer Bio7/27/2026Reiterated Rating$0.19Buy$0.0000.00% ROIVYGRVoyager Therapeutics7/20/2026Reiterated Rating$3.17Buy$0.0000.00% ROIATAIAtai Beckley7/20/2026Downgrade$7.22$7.50Neutral$0.0000.00% ROIHRMYHarmony Biosciences7/16/2026Reiterated Rating$33.18$55.00Buy$0.0000.00% ROIONCYOncolytics Biotech7/14/2026Reiterated Rating$0.93Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals7/13/2026Boost Price Target$288.04$485.00Buy$0.0000.00% ROIDTILPrecision BioSciences7/9/2026Reiterated Rating$9.28Buy$0.0000.00% ROICMPSCompass Pathways7/8/2026Reiterated Rating$13.17$70.00Buy$0.0000.00% ROIBEAMBeam Therapeutics7/7/2026Reiterated Rating$35.32$80.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals7/1/2026Reiterated Rating$82.09$100.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals6/29/2026Lower Price Target$291.37$470.00Buy$0.0000.00% ROIQUREuniQure6/29/2026Boost Price Target$47.51$80.00Buy$0.0000.00% ROIGOSSGossamer Bio6/25/2026Lower Price Target$13.84$160.00Buy$0.0000.00% ROIFTHSensei Biotherapeutics6/22/2026Initiated Coverage$17.82$60.00Buy$0.0000.00% ROIIran War Shock: What I Was Told In That Private Meeting (Ad)You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.Because THIS is the real reason.AGMBAgomAb Therapeutics6/22/2026Initiated Coverage$10.98$35.00Buy$0.0000.00% ROIQUREuniQure6/18/2026Reiterated Rating$48.16Buy$0.0000.00% ROIANROAlto Neuroscience6/17/2026Reiterated Rating$21.03Buy$0.0000.00% ROISLNSilence Therapeutics6/17/2026Reiterated Rating$6.71$75.00Buy$0.0000.00% ROIIVVDInvivyd6/15/2026Reiterated Rating$0.77$10.00Buy$0.0000.00% ROIATAIAtai Beckley6/8/2026Reiterated Rating$3.95$25.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals6/4/2026Reiterated Rating$303.52$510.00Buy$0.0000.00% ROIDRUGBright Minds Biosciences6/1/2026Reiterated Rating$84.06$145.00Buy$0.0000.00% ROIANROAlto Neuroscience5/27/2026Reiterated Rating$21.08$50.00Buy$0.0000.00% ROIDTILPrecision BioSciences5/27/2026Reiterated Rating$7.76$60.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics5/26/2026Reiterated Rating$3.80Buy$0.0000.00% ROIGOSSGossamer Bio5/26/2026Reiterated Rating$16.81$400.00Buy$0.0000.00% ROIONCYOncolytics Biotech5/26/2026Reiterated Rating$0.81$10.00Buy$0.0000.00% ROICMPSCompass Pathways5/22/2026Reiterated Rating$11.59Buy$0.0000.00% ROIGHRSGH Research5/19/2026Lower Price Target$21.68$65.00Buy$0.0000.00% ROIALTAltimmune5/18/2026Reiterated Rating$2.79$20.00Buy$0.0000.00% ROIANROAlto Neuroscience5/11/2026Reiterated Rating$25.45$50.00Buy$0.0000.00% ROIQUREuniQure5/6/2026Lower Price Target$21.61$50.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals5/5/2026Reiterated Rating$297.92$510.00Buy$0.0000.00% ROIASMBAssembly Biosciences5/4/2026Reiterated Rating$27.37$50.00Buy$0.0000.00% ROICMPSCompass Pathways4/28/2026Reiterated Rating$8.89$70.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals4/27/2026Reiterated Rating$2.94$45.00Buy$0.0000.00% ROIIMCRImmunocore4/20/2026Reiterated Rating$31.41$100.00Buy$0.0000.00% ROIIMCRImmunocore4/14/2026Reiterated Rating$31.62$100.00Buy$0.0000.00% ROIANROAlto Neuroscience4/2/2026Reiterated Rating$21.69$50.00Buy$0.0000.00% ROIASMBAssembly Biosciences3/26/2026Reiterated Rating$28.67$50.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals3/25/2026Reiterated Rating$325.35$510.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals3/25/2026Reiterated Rating$60.92$100.00Buy$0.0000.00% ROIATAIAtai Beckley3/17/2026Reiterated Rating$3.68$25.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics3/17/2026Reiterated Rating$3.96$25.00Buy$0.0000.00% ROIALTAltimmune3/16/2026Boost Price Target$3.60$25.00Buy$0.0000.00% ROISLNSilence Therapeutics3/13/2026Reiterated Rating$6.97$75.00Buy$0.0000.00% ROIALGSAligos Therapeutics3/11/2026Reiterated Rating$7.41$50.00Buy$0.0000.00% ROIQUREuniQure3/10/2026Reiterated Rating$17.99$70.00Buy$0.0000.00% ROIGOSSGossamer Bio3/6/2026Lower Price Target$41.74$400.00Buy$0.0000.00% ROIVIRVir Biotechnology3/4/2026Boost Price Target$8.91$20.00Buy$0.0000.00% ROIDRUGBright Minds Biosciences3/4/2026Boost Price Target$80.17$145.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals3/3/2026Boost Price Target$1.84$45.00Buy$0.0000.00% ROIPHVSPharvaris3/3/2026Reiterated Rating$27.37$60.00Buy$0.0000.00% ROIGHRSGH Research3/2/2026Boost Price Target$14.85$70.00Buy$0.0000.00% ROIATAIAtai Beckley3/2/2026Boost Price Target$3.63$25.00Buy$0.0000.00% ROICMPSCompass Pathways3/2/2026Boost Price Target$6.90$70.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics3/2/2026Boost Price Target$17.45$70.00Buy$0.0000.00% ROIHELPCybin3/2/2026Boost Price Target$7.35$95.00Buy$0.0000.00% ROIHRMYHarmony Biosciences2/25/2026Reiterated Rating$28.34$55.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals2/18/2026Reiterated Rating$332.30$510.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals2/10/2026Reiterated Rating$62.56$100.00Buy$0.0000.00% ROIQUREuniQure2/10/2026Reiterated Rating$26.05$70.00Buy$0.0000.00% ROISGMOSangamo Therapeutics2/10/2026Reiterated Rating$0.40$10.00Buy$0.0000.00% ROIIMCRImmunocore2/4/2026Reiterated Rating$32.07$100.00Buy$0.0000.00% ROIYour book attached (Ad)Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.Download the Safe Trade Options Formula book for free before access closesALNYAlnylam Pharmaceuticals1/30/2026Lower Price Target$346.79$510.00Buy$0.0000.00% ROIGOSSGossamer Bio1/22/2026Reiterated Rating$219.20$800.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals1/21/2026Reiterated Rating$2.18Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals1/21/2026Boost Price Target$67.01$100.00Buy$0.0000.00% ROIVIRVir Biotechnology12/30/2025Reiterated Rating$5.98$15.00Buy$0.0000.00% ROIDRUGBright Minds Biosciences12/30/2025Reiterated Rating$79.38$115.00Buy$0.0000.00% ROIASMBAssembly Biosciences12/22/2025Reiterated Rating$36.19$50.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals12/16/2025Reiterated Rating$1.98$40.00Buy$0.0000.00% ROIMRKRMarker Therapeutics12/8/2025Initiated Coverage$1.32$10.00Buy$0.0000.00% ROIMRKRMarker Therapeutics12/8/2025Initiated Coverage$1.42$10.00Buy$0.0000.00% ROIHRMYHarmony Biosciences12/3/2025Reiterated Rating$36.01Buy$0.0000.00% ROIPHVSPharvaris12/3/2025Reiterated Rating$28.08$60.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals12/2/2025Boost Price Target$56.25$85.00Buy$0.0000.00% ROIHRMYHarmony Biosciences11/24/2025Reiterated Rating$34.78$55.00Buy$0.0000.00% ROIONCYOncolytics Biotech11/17/2025Boost Price Target$1.04$10.00Buy$0.0000.00% ROIATAIAtai Beckley11/14/2025Reiterated Rating$4.13Buy$0.0000.00% ROIPHVSPharvaris11/13/2025Reiterated Rating$25.81$60.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics11/12/2025Lower Price Target$4.23$25.00Buy$0.0000.00% ROIGHRSGH Research11/10/2025Lower Price Target$13.54$35.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals11/4/2025Set Price Target$434.07$570.00Buy$0.0000.00% ROIQUREuniQure11/4/2025Lower Price Target$34.29$70.00Buy$0.0000.00% ROIIVVDInvivyd10/31/2025Boost Price Target$1.81$10.00Buy$0.0000.00% ROIANROAlto Neuroscience10/24/2025Boost Price Target$11.15$50.00Buy$0.0000.00% ROIIMCRImmunocore10/22/2025Reiterated Rating$31.57$100.00Buy$0.0000.00% ROIALTAltimmune10/20/2025Reiterated Rating$3.83$12.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals10/16/2025Reiterated Rating$3.17$40.00Buy$0.0000.00% ROIPHVSPharvaris10/15/2025Initiated Coverage$20.96$60.00Buy$0.0000.00% ROIPHVSPharvaris10/15/2025Initiated Coverage$21.78$60.00Buy$0.0000.00% ROIASMBAssembly Biosciences10/14/2025Reiterated Rating$27.66$50.00Buy$0.0000.00% ROIALTAltimmune10/10/2025Reiterated Rating$4.00$12.00Buy$0.0000.00% ROIBEAMBeam Therapeutics10/10/2025Reiterated Rating$27.87$80.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals10/10/2025Reiterated Rating$456.95$570.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals10/8/2025Reiterated Rating$36.54$80.00Buy$0.0000.00% ROIQUREuniQure10/6/2025Boost Price Target$54.92$110.00Buy$0.0000.00% ROIQUREuniQure10/6/2025Boost Price Target$54.92$110.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals10/1/2025Reiterated Rating$3.30$40.00Buy$0.0000.00% ROIHRMYHarmony Biosciences9/25/2025Lower Price Target$26.76$55.00Buy$0.0000.00% ROIQUREuniQure9/24/2025Reiterated Rating$39.80$70.00Buy$0.0000.00% ROIATAIAtai Beckley9/23/2025Reiterated Rating$5.36$15.00Buy$0.0000.00% ROISLNSilence Therapeutics9/16/2025Reiterated Rating$4.73$75.00Buy$00.0000.00% ROIBEAMBeam Therapeutics9/15/2025Reiterated Rating$20.60$80.00Buy$00.0000.00% ROIVYGRVoyager Therapeutics9/15/2025Reiterated Rating$4.18$30.00Buy$0.0000.00% ROIDRUGBright Minds Biosciences9/15/2025Reiterated Rating$48.75$85.00Buy$00.0000.00% ROIVIRVir Biotechnology9/15/2025Reiterated Rating$4.80$15.00Buy$00.0000.00% ROIALGSAligos Therapeutics9/12/2025Reiterated Rating$10.31$50.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals9/8/2025Initiated Coverage$2.75$40.00Buy$0.0000.00% ROIQUREuniQure9/5/2025Reiterated Rating$17.56$70.00Buy$00.0000.00% ROISGMOSangamo Therapeutics9/4/2025Reiterated Rating$0.53$10.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals9/2/2025Reiterated Rating$446.87$570.00Buy$000.0000.00% ROIARWRArrowhead Pharmaceuticals9/2/2025Reiterated Rating$24.88$80.00Buy$00.0000.00% ROIReady to give options a try? Your first trade (Ticker included) -INSIDE (Ad)Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.Send me my free guideIVVDInvivyd8/27/2025Reiterated Rating$1.03$5.00Buy$0.0000.00% ROIDRUGBright Minds Biosciences8/19/2025Reiterated Rating$42.25$85.00Buy$00.0000.00% ROIALGSAligos Therapeutics8/18/2025Initiated Coverage$7.70$50.00Buy$0.0000.00% ROIASMBAssembly Biosciences8/18/2025Initiated Coverage$25.44$50.00Buy$00.0000.00% ROIANROAlto Neuroscience8/18/2025Reiterated Rating$3.30$10.00Buy$00.0000.00% ROIALTAltimmune8/13/2025Reiterated Rating$3.85$12.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals8/7/2025Boost Price Target$428.14$570.00Buy$000.0000.00% ROICMPSCompass Pathways8/4/2025Lower Price Target$4.73$40.00Buy$00.0000.00% ROIATAIAtai Beckley7/30/2025Reiterated Rating$3.49$15.00Buy$0.0000.00% ROICMPSCompass Pathways7/15/2025Reiterated Rating$3.64$45.00Buy$00.0000.00% ROIALTAltimmune6/27/2025Reiterated Rating$3.61$12.00Buy$0.0000.00% ROIANROAlto Neuroscience6/26/2025Reiterated Rating$2.32$10.00Buy$00.0000.00% ROIIVVDInvivyd6/26/2025Reiterated Rating$0.77$5.00Buy$0.0000.00% ROISGMOSangamo Therapeutics6/24/2025Reiterated Rating$0.50$10.00Buy$0.0000.00% ROISLNSilence Therapeutics6/13/2025Reiterated Rating$5.59$75.00Buy$0.0000.00% ROIIMCRImmunocore6/2/2025Reiterated Rating$38.51$100.00Buy$00.0000.00% ROIQUREuniQure5/29/2025Reiterated Rating$15.33$70.00Buy$00.0000.00% ROIIVVDInvivyd5/28/2025Lower Price Target$0.88$5.00Buy$0.0000.00% ROIONCYOncolytics Biotech5/21/2025Reiterated Rating$0.43$5.00Buy$0.0000.00% ROIDTILPrecision BioSciences5/21/2025Reiterated Rating$4.88$60.00Buy$0.0000.00% ROIATAIAtai Beckley5/20/2025Reiterated Rating$1.84$10.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals5/20/2025Reiterated Rating$15.74$80.00Buy$00.0000.00% ROICMPSCompass Pathways5/12/2025Reiterated Rating$3.79$45.00Buy$0.0000.00% ROIGHRSGH Research5/9/2025Reiterated Rating$10.94$40.00Buy$00.0000.00% ROIQUREuniQure4/21/2025Reiterated Rating$13.72$70.00Buy$00.0000.00% ROIVYGRVoyager Therapeutics4/8/2025Reiterated Rating$2.93$30.00Buy$0.0000.00% ROIHRMYHarmony Biosciences4/8/2025Reiterated Rating$28.33$70.00Buy$00.0000.00% ROIBEAMBeam Therapeutics4/7/2025Reiterated Rating$15.27$80.00Buy$00.0000.00% ROISGMOSangamo Therapeutics4/7/2025Reiterated Rating$0.66$10.00Buy$0.0000.00% ROIANROAlto Neuroscience4/7/2025Initiated Coverage$1.87$10.00Buy$00.0000.00% ROIALTAltimmune4/3/2025Reiterated Rating$4.61$12.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals4/2/2025Reiterated Rating$261.73$500.00Buy$000.0000.00% ROIDTILPrecision BioSciences3/28/2025Reiterated Rating$4.54$60.00Buy$0.0000.00% ROIMISTMilestone Pharmaceuticals3/28/2025Reiterated Rating$0.95$25.00Buy$0.0000.00% ROIIVVDInvivyd3/26/2025Reiterated Rating$0.66$10.00Buy$0.0000.00% ROIATAIAtai Beckley3/19/2025Reiterated Rating$1.38$10.00Buy$0.0000.00% ROIDTILPrecision BioSciences3/19/2025Reiterated Rating$4.91$60.00Buy$0.0000.00% ROIGOSSGossamer Bio3/18/2025Reiterated Rating$111.20$800.00Buy$00.0000.00% ROIALTAltimmune3/18/2025Reiterated Rating$5.97$12.00Buy$0.0000.00% ROIMISTMilestone Pharmaceuticals3/17/2025Reiterated Rating$2.45$25.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics3/13/2025Reiterated Rating$4.06$30.00Buy$0.0000.00% ROIIMCRImmunocore3/12/2025Reiterated Rating$28.42$100.00Buy$00.0000.00% ROIBEAMBeam Therapeutics3/10/2025Reiterated Rating$24.32$80.00Buy$00.0000.00% ROIONCYOncolytics Biotech3/10/2025Reiterated Rating$0.66$5.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics3/7/2025Reiterated Rating$6.61$55.00Buy$00.0000.00% ROISLNSilence Therapeutics3/7/2025Reiterated Rating$4.74$75.00Buy$0.0000.00% ROICMPSCompass Pathways3/4/2025Reiterated Rating$3.75$45.00Buy$0.0000.00% ROIQUREuniQure3/4/2025Reiterated Rating$10.76$70.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics3/3/2025Reiterated Rating$4.00$30.00Buy$0.0000.00% ROIALTAltimmune3/3/2025Reiterated Rating$6.24$12.00Buy$0.0000.00% ROIMy top 3 AI picks for the next decade (Ad)Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.Click here to get all three AI stock names from Alexander GreenBEAMBeam Therapeutics2/28/2025Reiterated Rating$27.27$80.00Buy$00.0000.00% ROIMISTMilestone Pharmaceuticals2/28/2025Reiterated Rating$1.75$25.00Buy$0.0000.00% ROIVIRVir Biotechnology2/28/2025Reiterated Rating$8.01$110.00Buy$0.0000.00% ROIIMCRImmunocore2/28/2025Reiterated Rating$29.13$100.00Buy$00.0000.00% ROIHRMYHarmony Biosciences2/27/2025Lower Price Target$33.47$70.00Buy$00.0000.00% ROIIVVDInvivyd2/24/2025Reiterated Rating$1.43$10.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals2/24/2025Boost Price Target$252.00$500.00Buy$000.0000.00% ROIDTILPrecision BioSciences2/19/2025Reiterated Rating$5.63$60.00Buy$0.0000.00% ROIDRUGBright Minds Biosciences2/19/2025Reiterated Rating$38.78$85.00Buy$00.0000.00% ROIHRMYHarmony Biosciences2/19/2025Reiterated Rating$36.43$75.00Buy$00.0000.00% ROIATAIAtai Beckley2/13/2025Reiterated Rating$2.55$10.00Buy$0.0000.00% ROIHELPCybin2/13/2025Lower Price Target$9.36$150.00Buy$0.0000.00% ROICMPSCompass Pathways2/13/2025Lower Price Target$4.25$45.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals2/12/2025Reiterated Rating$18.57$80.00Buy$00.0000.00% ROIALTAltimmune2/5/2025Reiterated Rating$6.88$12.00Buy$0.0000.00% ROIIVVDInvivyd2/4/2025Reiterated Rating$1.06$10.00Buy$0.0000.00% ROIBEAMBeam Therapeutics2/3/2025Reiterated Rating$25.92$80.00Buy$00.0000.00% ROIONCYOncolytics Biotech2/3/2025Reiterated Rating$0.73$5.00Buy$0.0000.00% ROIVIRVir Biotechnology1/31/2025Reiterated Rating$10.31$110.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics1/31/2025Reiterated Rating$7.13$55.00Buy$00.0000.00% ROIGOSSGossamer Bio1/30/2025Reiterated Rating$73.49$800.00Buy$000.0000.00% ROISLNSilence Therapeutics1/29/2025Reiterated Rating$5.28$75.00Buy$0.0000.00% ROIATAIAtai Beckley1/28/2025Reiterated Rating$1.42$10.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics1/27/2025Reiterated Rating$5.62$30.00Buy$0.0000.00% ROIQUREuniQure1/27/2025Boost Price Target$15.67$70.00Buy$00.0000.00% ROIGHRSGH Research1/27/2025Reiterated Rating$8.83$40.00Buy$00.0000.00% ROIIMCRImmunocore1/27/2025Reiterated Rating$33.00$100.00Buy$00.0000.00% ROISGMOSangamo Therapeutics1/27/2025Reiterated Rating$1.16$10.00Buy$0.0000.00% ROIMISTMilestone Pharmaceuticals1/27/2025Reiterated Rating$2.05$25.00Buy$0.0000.00% ROIHRMYHarmony Biosciences1/27/2025Reiterated Rating$38.01$75.00Buy$00.0000.00% ROIHELPCybin1/27/2025Reiterated Rating$9.46$190.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals1/23/2025Reiterated Rating$19.71$80.00Buy$00.0000.00% ROIALTAltimmune1/22/2025Reiterated Rating$6.94$12.00Buy$0.0000.00% ROIHRMYHarmony Biosciences1/16/2025Reiterated Rating$37.62$75.00Buy$00.0000.00% ROIALNYAlnylam Pharmaceuticals1/13/2025Reiterated Rating$249.59$400.00Buy$000.0000.00% ROIDRUGBright Minds Biosciences1/10/2025Initiated Coverage$41.04$85.00Buy$00.0000.00% ROIDTILPrecision BioSciences1/10/2025Reiterated Rating$4.50$60.00Buy$0.0000.00% ROIGHRSGH Research1/10/2025Reiterated Rating$8.40$40.00Buy$00.0000.00% ROIHRMYHarmony Biosciences12/17/2024Initiated Coverage$33.06$75.00Buy$00.0000.00% ROIBNTCBenitec Biopharma12/16/2024Initiated Coverage$11.77$28.00Buy$00.0000.00% ROIBEAMBeam Therapeutics12/9/2024Reiterated Rating$27.02$80.00Buy$00.0000.00% ROIBEAMBeam Therapeutics11/7/2024Reiterated Rating$26.62$80.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.